Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 91

Sort by

Sort Order Select

Journal Articles

Dynamics of Activated CD8+ T-cells and Decreased Osteoclasts in the Tumor Microenvironment are Associated with Clinical Efficacy of Anti-PD-L1 and Anti-CD38 Combination Treatment in Relapsed or Refractory Multiple Myeloma

Aparna Raval, PhD, Hearn Jay Cho, MD PhD, Cherie Green, BS, Elisabeth Wassner Fritsch, PharmD, Connie Ma, MS, Naomi Chang, MSc, Mark Yan, PhD, Mark Kockx, MD PhD, Shine Shen, MS, Ling-Yuh Huw, PhD, Emily Balestiere, BA, Marina Lipkind, BS, Huang Huang, MSc, Michelle Byrtek, PhD, Dawn Colburn, PharmD, BCOP, Sandy W. Wong, Jeffrey M. Venstrom, MD PhD, Joanne I Adamkewicz, PhD

Blood (2019) 134 (Supplement_1): 1907.

https://doi.org/10.1182/blood-2019-123652

Published: 2019

Journal Articles

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

Swagatika Samal, MBBS MD, Shruti Mishra, MBBS, MD PDF Hematology, Rasheeda Mohamedali, MBBS, Kishore Kumar, MBBS, MD DM

Blood (2019) 134 (Supplement_1): 4867.

https://doi.org/10.1182/blood-2019-131393

Published: 2019

Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Anas Younes, MD, John M Burke, MD, Bruce D. Cheson, MD, Catherine Diefenbach, MD, Silvia Ferrari, MD, Uwe H Hahn, MD, Eliza A Hawkes, Cyrus Khan, MD, Izidore S. Lossos, MD, Gerardo Musuraca, MD PhD, Monica Tani, Umberto Vitolo, Sam Lung Sang Yuen, MBBS,FRCPA,FRACP, Aparna Raval, PhD, Mahesh R. Shivhare, PhD, Tina G Nielsen, MD PhD, Gila Sellam, PhD, Jeff P. Sharman, MD

Blood (2019) 134 (Supplement_1): 2874.

https://doi.org/10.1182/blood-2019-123368

Published: 2019

Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Experience from a Single UK Centre

John Radford, Ellie White, Felipe A. Castro, PhD, Anshuman Chaturvedi, FRCPath, Nathalie Spielewoy, PhD, Adam Gibb, MBBS, Andy Surinach, MPH, Kim Linton, PhD, Aijing Shang, MD PhD, Michael Wenger, MD

Blood (2019) 134 (Supplement_1): 2917.

https://doi.org/10.1182/blood-2019-123664

Published: 2019

Journal Articles

Metastatic Lymphoepithelioma-like Carcinoma Treated with PD1-Antibody:Is Epstein-Barr Virus Eradication the Main Mechanism in 2 Refractory Cases in Children?

Haixia Guo, MD PhD, Xuedong Wu, MD PhD, Na LI, Jian LI

Blood (2019) 134 (Supplement_1): 5615.

https://doi.org/10.1182/blood-2019-129871

Published: 2019

Journal Articles

Eltrombopag Promotes Megakaryocyte Survival and Signaling in the Presence of Specific Cytotoxic Agents

Komal Kumar Javarappa, PhD, Dimitrios Tsallos, BSc(Hons), MSc, Bulat Zagidullin, MSc, Joseph J Saad, MSc, BSc, Jing Tang, PhD, Pedro Marques Ramos, PhD, Celine Pallaud, PhD, Caroline A Heckman, PhD

Blood (2018) 132 (Supplement 1): 3836.

https://doi.org/10.1182/blood-2018-99-118449

Published: 2018

Journal Articles

Polycomb Group Proteins Recruit TET1 to Remove Aberrant DNA Methylation in Murine Embryonic Stem Cells

Yong Lei, PhD, Margaret A. Goodell, PhD

Blood (2018) 132 (Supplement 1): 2571.

https://doi.org/10.1182/blood-2018-99-116841

Published: 2018

Journal Articles

Reversal of Chemoresistance in Leukemia Cells Using Synthetic Bisbenzylisoquinoline Derivatives

Martin Müller, Susanne Gerndt, Anja Arner, Yu-Kai Chao, Linus Schömig, Carina Atzberger, Martin Biel, Franz Bracher, Angelika Vollmar, Vera Binder, MD, Marco Keller, Christian Grimm, Karin Bartel

Blood (2018) 132 (Supplement 1): 3504.

https://doi.org/10.1182/blood-2018-99-111651

Published: 2018

Journal Articles

Stathmin 1 Is Highly Expressed in Acute Promyelocytic Leukemia and Microtubule Dynamics Is a Potential Target for ATRA-Resistant APL Cells

João Agostinho Machado-Neto, BSc, Juan Luiz Coelho-Silva, BSc, MSc, Antonio R. Lucena-Araujo, PhD, Priscila S Scheucher, PhD, Raul Antônio Morais Melo, MD PhD, Rosane Bittencourt, MD, Ricardo Pasquini, MD, Katia B B Pagnano, MD PhD, Evandro Maranhão Fagundes, MD, Maria de Lourdes Chauffaille, MD PhD, Carlos Chiattone, MD, Eduardo Magalhães Rego, MDPhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 2514.

https://doi.org/10.1182/blood.V130.Suppl_1.2514.2514

Published: 2017

Journal Articles

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Nathalie Meurice, PhD, Joachim L Petit, PhD, Cecilia Bonolo De Campos, PhD, Alysia N Polito, BS, Ilsel D Lopez Armenta, BS, Gregory J Ahmann, BS, Laura Ann Bruins, BS, Joseph R Mikhael, MD FRCPC, MD, Craig B. Reeder, MD, Angela A Mayo, MS, PA-C, P. Leif Bergsagel, MD, Rafael Fonseca, MD, Nikolai Sepetov, PhD, Sergei Romanov, PhD, A. Keith Stewart, MBChB, MBA

Blood (2017) 130 (Supplement 1): 3080.

https://doi.org/10.1182/blood.V130.Suppl_1.3080.3080

Published: 2017

Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens

Blood (2017) 130 (Supplement 1): 5165.

https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165

Published: 2017

Journal Articles

Cotylenin Α, a Fusicoccane Diterpene Glycoside with a Complex Sugar Moiety, and Vincristine Synergistically Inhibit the Growth of Myeloma Cell in Vitro and in Vivo

Tsutomu Takahashi, MD PhD, Yoshio Honma, PhD, Koshi Kawakami, MDPhD, Junji Suzumiya

Blood (2014) 124 (21): 5721.

https://doi.org/10.1182/blood.V124.21.5721.5721

Published: 2014

Journal Articles

Use of Chemotherapy and Same-Day Pegfilgrastim Prophylaxis in US Clinical Practice

Derek Weycker, PhD, Hongsheng Wu, PhD, May Hagiwara, PhD, Xiaoyan Li, PhD, Richard L Barron, MS

Blood (2014) 124 (21): 4825.

https://doi.org/10.1182/blood.V124.21.4825.4825

Published: 2014

Journal Articles

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Hairong Xu, MD, PhD, Lanfang Xu, MS, John H Page, MD ScD, Olivia Sattayapiwat, MS, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2014) 124 (21): 4822.

https://doi.org/10.1182/blood.V124.21.4822.4822

Published: 2014

Journal Articles

Focal Adhesion Kinase Inhibitors Reverse the Stromal Adhesion Phenotype of Ikaros-Mutant B-ALL, Induce Apopotosis, and Synergize with ABL1 Tyrosine Kinase Inhibitors: A New Paradigm for Pathogenesis and Therapy of High-Risk B-ALL

Ila Joshi, PhD, Nilamani Jena, PhD, Toshimi Yoshida, PhD, Leto Paraskevopoulou, BS, Zhihong Zhang, PhD, Zhong-Ying Liu, MDPhD, Shane Korber, Daniela S. Krause, MD, Irina M. Shapiro, PhD, David T. Weaver, PhD, Jonathan A. Pachter, PhD, Elisabeth M. Paietta, PhD, Richard A. Van Etten, MDPhD, Katia Georgopoulos, PhD

Blood (2014) 124 (21): 285.

https://doi.org/10.1182/blood.V124.21.285.285

Published: 2014

Journal Articles

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Adriana Silva Santos Duarte, PhD, Irene Lorand-Metze, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3229.

https://doi.org/10.1182/blood.V124.21.3229.3229

Published: 2014

Journal Articles

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Xuelan Zuo, Ying Wang, Yi Zhou, Lin Luo, Minghui Liu

Blood (2014) 124 (21): 5271.

https://doi.org/10.1182/blood.V124.21.5271.5271

Published: 2014

Journal Articles

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Wilhelm Woessmann, MD, Martin Zimmermann, Birgit Burkhardt, Andrea Meinhardt, MD, Christine Rosenbusch, MD, Vera Vaillant, MD, Ilske Oschlies, Wolfram Klapper, MD, Felix Niggli, MD, Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2014) 124 (21): 1738.

https://doi.org/10.1182/blood.V124.21.1738.1738

Published: 2014

Journal Articles

Causes and Consequences of Cancer-Associated Thrombocytosis

Anil Sood, MD, Rebecca L. Stone, M, D., Vahid Afshar-Kharghan, MD

Blood (2013) 122 (21): SCI-33.

https://doi.org/10.1182/blood.V122.21.SCI-33.SCI-33

Published: 2013

Journal Articles

Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy

Derek Weycker, Ph.D., Xiaoyan Li, Ph.D., Alex Kartashov, Ph.D., Rich Barron, M.S., John Edelsberg, M.D., M.P.H., Hairong Xu, M.D., Ph.D., Vincent Girardi, M.S., Gary H. Lyman, M.D., M.P.H.

Blood (2013) 122 (21): 2962.

https://doi.org/10.1182/blood.V122.21.2962.2962

Published: 2013

NARROW

Dynamics of Activated CD8+ T-cells and Decreased Osteoclasts in the Tumor Microenvironment are Associated with Clinical Efficacy of Anti-PD-L1 and Anti-CD38 Combination Treatment in Relapsed or Refractory Multiple Myeloma

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Experience from a Single UK Centre

Metastatic Lymphoepithelioma-like Carcinoma Treated with PD1-Antibody:Is Epstein-Barr Virus Eradication the Main Mechanism in 2 Refractory Cases in Children?

Eltrombopag Promotes Megakaryocyte Survival and Signaling in the Presence of Specific Cytotoxic Agents

Polycomb Group Proteins Recruit TET1 to Remove Aberrant DNA Methylation in Murine Embryonic Stem Cells

Reversal of Chemoresistance in Leukemia Cells Using Synthetic Bisbenzylisoquinoline Derivatives

Stathmin 1 Is Highly Expressed in Acute Promyelocytic Leukemia and Microtubule Dynamics Is a Potential Target for ATRA-Resistant APL Cells

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Cotylenin Α, a Fusicoccane Diterpene Glycoside with a Complex Sugar Moiety, and Vincristine Synergistically Inhibit the Growth of Myeloma Cell in Vitro and in Vivo

Use of Chemotherapy and Same-Day Pegfilgrastim Prophylaxis in US Clinical Practice

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Focal Adhesion Kinase Inhibitors Reverse the Stromal Adhesion Phenotype of Ikaros-Mutant B-ALL, Induce Apopotosis, and Synergize with ABL1 Tyrosine Kinase Inhibitors: A New Paradigm for Pathogenesis and Therapy of High-Risk B-ALL

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Causes and Consequences of Cancer-Associated Thrombocytosis

Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only